MIZUHO MEDY CO.,LTD.
4595JapanPharmaceutical
MIZUHO MEDY CO.,LTD. (4595) reported JPY 11.3bn of revenue in the financial year ended 2025-12-31.
Reported financials
Figures are as filed, in billions of yen (JPY bn). We do not convert to dollars — an exchange rate would be a number we made up, not one the company reported. Statements are on a standalone basis.
| Financial year ended | 2025-12-31 |
|---|---|
| Revenue | 11.3 |
| Operating profit | 4.6 |
| Net profit | 3.4 |
| Total assets | 22.4 |
| Equity | 18.7 |
Ratios from those figures
Each ratio is computed from the two lines above it. A dash means an input was missing or the denominator was zero — not that the value is zero.
| Operating margin | 41.3% |
|---|---|
| Net margin | 30.4% |
| Equity / assets | 83.5% |
| Return on equity | 18.3% |
| Asset turnover | 0.5 |
These are arithmetic, not judgements. We do not say whether a margin is good or bad, and we do not rank companies against each other.
What the market puts on it
| Market capitalisation | JPY 32.5bn |
|---|---|
| Share price | JPY 1,708.48 |
| Shares | 19,051,000 |
| Earnings per share | JPY 179.84 |
| Book value per share | JPY 980.89 |
| Price / earnings | 9.5 |
| Price / book | — |
We could not compute price to book here. Reason recorded at collection: BPS basis (consolidated or parent-only) is not stated in the filing
Market capitalisation is what buyers are betting the company is worth. It is not something the company produced, so we never present it as output or productivity.
Who runs it
The representative named on the cover of the company's annual securities report (有価証券報告書), filed with Japan's Financial Services Agency through EDINET. In Japan this is the office a CEO holds. The report names one representative on its cover.
| Name | 唐川 文成 |
|---|---|
| Title | Representative Director and Chairman (CEO), President (代表取締役会長兼社長) |
The name is printed as it was filed, in Japanese. We do not romanise it — a kanji name can be read several ways and only the person knows which one is theirs. Writing a guess here would put the wrong name on this page.
Other companies in Pharmaceutical
79 listed companies file under this classification. Showing 12.
- Mochida Pharmaceutical Co.,Ltd.
- Medrx Co.,Ltd.
- Modalis Therapeutics Corporation
- Kyowa Kirin Co., Ltd.
- MORISHITA JINTAN CO., LTD.
- KYORIN Pharmaceutical Co., Ltd.
- MUROMACHI CHEMICALS INC.
- Kubota Pharmaceutical Holdings Co., Ltd.
- Nano Holdings, Inc.
- Kringle Pharma, Inc.
- NIPPON CHEMIPHAR CO., LTD.
- Kohjin Bio Co., Ltd.